In mysterious FDA approval, Pfizer quietly wins Ibrance breast cancer expansion

In mysterious FDA approval, Pfizer quietly wins Ibrance breast cancer expansion

Source: 
Fierce Pharma
snippet: 

It’s unusual to have the FDA chase down a pharma company and ask them apply for a new drug indication. But Pfizer went through just that and has now quietly revealed a label expansion for blockbuster breast cancer med Ibrance.